Athanasios Manole, MD
Interventional Pain Medicine · Albuquerque, NMNPI 1780002220
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,910 of the $8,790 with a category attached, or 78.6%. It is spread thinly across 30 manufacturers, the largest accounting for just 24.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,011, more than ten times the $39 reported in 2020.
Across 330 payments — averaging $26.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Zimmer Biomet$1K
- Medtronic$1K
- Nevro Corp.$1K
- Abbott$500
- Globus Medical$480
- plus $2K from 24 others
What the payments were for
- Travel & lodging$1,88021%
- Food & beverage$6,91079%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 161 | $2,109 |
| Zimmer Biomet | 11 | $1,343 |
| Medtronic | 23 | $1,319 |
| Nevro Corp. | 48 | $1,278 |
| Abbott | 17 | $500 |
| Globus Medical | 12 | $480 |
| AstraZeneca | 2 | $244 |
| Pfizer | 11 | $200 |
| Merz Pharmaceuticals, LLC | 4 | $195 |
| Teva Pharmaceuticals USA, Inc. | 2 | $183 |
| GRT US Holding, Inc. | 5 | $143 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $125 |
| Alkermes, Inc. | 1 | $122 |
| Biohaven Pharmaceuticals, Inc. | 3 | $77 |
| Lundbeck LLC | 4 | $73 |
| Lilly USA, LLC | 5 | $64 |
| Johnson & Johnson | 4 | $55 |
| Nalu Medical, Inc. | 2 | $34 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $32 |
| Medline Industries LP | 2 | $28 |
| SPR Therapeutics, Inc | 1 | $27 |
| Bioventus LLC | 1 | $25 |
| Ultragenyx Pharmaceutical Inc. | 1 | $24 |
| Biodelivery Sciences International, Inc. | 1 | $20 |
| Impel Pharmaceuticals Inc. | 1 | $19 |
| Vertos Medical, Inc. | 1 | $19 |
| IBSA Pharma Inc. | 1 | $18 |
| Ferring Pharmaceuticals Inc. | 1 | $17 |
| Vertex | 1 | $15 |
| Electronic Waveform Lab, Inc. | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few interventional pain medicine providers in New Mexicoto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 483 | $9,294 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 268 | $8,759 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 47 | $8,084 |
| Oxycodone Hcl | 313 | $6,660 |
| Gabapentin | 499 | $6,148 |
| Buprenorphine Hcl | 156 | $5,597 |
| Naloxone Hcl | 66 | $4,283 |
| Pregabalin | 194 | $4,182 |
| Morphine Sulfate ErMorphine Sulfate | 42 | $2,639 |
| Tizanidine Hcl | 339 | $2,328 |
| Buprenorphine | 14 | $2,119 |
| Baclofen | 92 | $2,083 |
| Tramadol Hcl | 144 | $1,480 |
| Duloxetine Hcl | 69 | $1,426 |
| Butalb-Acetaminoph-Caff-CodeinButalbit/Acetamin/Caff/Codeine | 15 | $1,346 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Albuquerque
- Reuel MeasomAlbuquerque$49K
- Diego GonzalezAlbuquerque$35K
- Craig NairnAlbuquerque$4K
- Edward PoonAlbuquerque$2K
- Kyle SchoenbergerAlbuquerque$2K
- Michael MalizzoAlbuquerque$462
- Cesar VelardeLas Cruces$3K
- Jose RamirezLas Cruces$714
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.